caa a22 4500 605491186 CHVBK 20210128100508.0 cr unu---uuuuu 210128e20150801xx s 000 0 eng 10.1007/s10147-014-0774-3 doi (NATIONALLICENCE)springer-10.1007/s10147-014-0774-3 Transoral robotic surgery in management of oropharyngeal cancers: a preliminary experience at a tertiary cancer centre in India [Elektronische Daten] [Surender Dabas, Abhinav Dewan, Reetesh Ranjan, Ajay Dewan, Anoop Puri, Swati Shah, Rupal Sinha] Background: The aim of this observational prospective study was to determine the technical feasibility, safety and adequacy of surgical margins for transoral robotic surgery (TORS) in oropharyngeal cancers. Methods: From March 2013 to May 2014, 60 patients with oropharyngeal lesions underwent TORS with or without neck dissection using the ‘DaVinci' robot. Patients were observed and data recorded on surgical time, blood loss, complications and functional outcome of patients. Results: All 60 patients underwent TORS, with neck dissection performed in 45 of the patients. A positive margin was seen in two patients (3.3%). Intent to treatment was radical in 42 patients and salvage in 18 patients. None of the patients required tracheostomy, and one patient (1.66%) died postoperatively. Postoperative complications in the form of primary haemorrhage required active intervention in three patients. Average estimated blood loss was 26.5±31.1ml. Postoperatively, all patients had adequate swallowing and speech function with nasal twang reported in three patients on long-term follow up. Patients started tolerating oral feeds within a week of procedure (mean 3.96days), with the nasogastric tube removed on the ninth postoperative day (mean 9.19days). No long-term gastrostomy tube dependency was reported. Conclusion: TORS is a safe, feasible, minimally invasive procedure in patients with oropharyngeal cancers. It has the least morbidity and offers benefits in terms of avoidance of tracheostomy tube, prolonged Ryle's tube and gastrostomy dependency. Japan Society of Clinical Oncology, 2014 TORS nationallicence Oropharyngeal cancer nationallicence DaVinci Robot nationallicence Head and neck cancers nationallicence Dabas Surender Department of Surgical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India aut Dewan Abhinav Department of Radiation Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India aut Ranjan Reetesh Department of Surgical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India aut Dewan Ajay Department of Surgical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India aut Puri Anoop Department of Surgical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India aut Shah Swati Department of Surgical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India aut Sinha Rupal Department of Research, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India aut International Journal of Clinical Oncology Springer Japan 20/4(2015-08-01), 693-700 1341-9625 20:4<693 2015 20 10147 https://doi.org/10.1007/s10147-014-0774-3 text/html Onlinezugriff via DOI BK010053 XK010053 XK010000 Metadata rights reserved Springer special CC-BY-NC licence nationallicence 1 research-article jats NATIONALLICENCE NATIONALLICENCE NL-springer NATIONALLICENCE 856 40 https://doi.org/10.1007/s10147-014-0774-3 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Dabas Surender Department of Surgical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India aut NATIONALLICENCE 700 1- Dewan Abhinav Department of Radiation Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India aut NATIONALLICENCE 700 1- Ranjan Reetesh Department of Surgical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India aut NATIONALLICENCE 700 1- Dewan Ajay Department of Surgical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India aut NATIONALLICENCE 700 1- Puri Anoop Department of Surgical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India aut NATIONALLICENCE 700 1- Shah Swati Department of Surgical Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India aut NATIONALLICENCE 700 1- Sinha Rupal Department of Research, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India aut NATIONALLICENCE 773 0- International Journal of Clinical Oncology Springer Japan 20/4(2015-08-01), 693-700 1341-9625 20:4<693 2015 20 10147